The expanding demand for specific immunological research and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression systems, including microbial hosts, animal cell cultures, and viral